HSPA5 and glioma: Interestingly, EGCG had previously been found to bind to the ATP-binding domain of glucose regulate protein 78 (GRP78), blocking its UPR protective function and sensitizing glioma cells against chemotherapeutic agents such as etoposide.49 These findings indicated that EGCG may suppress the UPR signaling through different ways.